20 units and beyond: where is the line between utility and futility? Authors: Eugenia Ester Lee, Kazuhide Matsushima Published: 2026 The utility of ultra massive transfusion, defined by over 20 units of packed red blood cells within 24 hours, remains a subject of ongoing debate and increasing scrutiny in the trauma community. During resuscitation of the severely injured patient, early identification of those most likely to benefit from this resource-intensive intervention is critical, as is the timely recognition of patients for whom continued escalation of care is likely to be futile. This case series by Miller et al studying ultra massive transfusion demonstrates a 52% survival to discharge in a patient population receiving an average of 45 units of blood within the first 24 hours.1 This is higher than expected survival compared with available literature, which reported closer to 60–70% mortality.2–5 They identify other factors that may contribute to their outcomes, including patient’s age, injury severity score, co-morbidities, initial vitals, and Glasgow Coma Scale, tranexamic acid administration, and transport times.1 Although limited by its small sample size of 27 patients from a single institution, the study highlights that existing data on survival among patients requiring ultra-massive transfusion may not be broadly generalizable across institutions, patient populations, and practice settings. Other studies have consistently demonstrated that transfusion volume among patients requiring massive transfusion is not independently associated with in-hospital mortality, and have failed to identify a transfusion threshold beyond which resuscitation becomes futile.2–5 Ultimately, it is unlikely that a single transfusion volume or rate will serve as a definitive framework for decision-making. The determination of appropriate resource usage depends on the physician’s clinical judgment, informed by experience and expertise. Ultra-massive transfusion represents one of the most resource-intensive interventions in trauma care, and its appropriate use requires a careful balance between the potential for survival and the recognition of when continued efforts are unlikely to provide meaningful benefit. The authors provide compelling evidence highlighting the need for a more nuanced approach that incorporates patient physiology, injury pattern, response to resuscitation, and clinical trajectory. The study reinforces the importance of identifying the patients most likely to benefit from this extraordinary effort while developing strategies to ensure that these resources are used thoughtfully and effectively. Ultimately, the decision to pursue ultra-massive transfusion cannot be reduced to a single number, but rather requires the experience, judgment, and expertise of the trauma team caring for the individual patient. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Provenance and peer review: Commissioned; internally peer reviewed. References